144 related articles for article (PubMed ID: 27123491)
41. [Significance of IKZF1 gene copy number abnormalities in BCR/ABL-negative B-lineage acute lymphoblastic leukemia in children].
Zou Y; Liu XM; Zhang L; Chen YM; Guo Y; Chen XJ; Yang WY; Wang SC; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1154-9. PubMed ID: 26575870
[TBL] [Abstract][Full Text] [Related]
42. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.
Hiscox S; Barnfather P; Hayes E; Bramble P; Christensen J; Nicholson RI; Barrett-Lee P
Breast Cancer Res Treat; 2011 Feb; 125(3):659-69. PubMed ID: 20354780
[TBL] [Abstract][Full Text] [Related]
44. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.
Tharkar-Promod S; Johnson DP; Bennett SE; Dennis EM; Banowsky BG; Jones SS; Shearstone JR; Quayle SN; Min C; Jarpe M; Mosbruger T; Pomicter AD; Miles RR; Chen WY; Bhalla KN; Zweidler-McKay PA; Shrieve DC; Deininger MW; Chandrasekharan MB; Bhaskara S
Leukemia; 2018 Jan; 32(1):49-60. PubMed ID: 28579617
[TBL] [Abstract][Full Text] [Related]
45. Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.
Masuzawa A; Kiyotani C; Osumi T; Shioda Y; Iijima K; Tomita O; Nakabayashi K; Oboki K; Yasuda K; Sakamoto H; Ichikawa H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Mori T
Eur J Haematol; 2014 Mar; 92(3):263-7. PubMed ID: 24215620
[TBL] [Abstract][Full Text] [Related]
46. Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.
Bhandari P; Ahmad F; Das BR
Med Oncol; 2017 May; 34(5):92. PubMed ID: 28401483
[TBL] [Abstract][Full Text] [Related]
47. mTOR inhibition enhances efficacy of dasatinib in
Gotesman M; Vo TT; Herzog LO; Tea T; Mallya S; Tasian SK; Konopleva M; Fruman DA
Oncotarget; 2018 Jan; 9(5):6562-6571. PubMed ID: 29464092
[TBL] [Abstract][Full Text] [Related]
48. A pH/UV-B Synergism in Amphibians.
Long LE; Saylor LS; Soulé ME
Conserv Biol; 1995 Oct; 9(5):1301-1303. PubMed ID: 34261269
[No Abstract] [Full Text] [Related]
49. [B. Bringedal responds].
Bringedal B
Tidsskr Nor Laegeforen; 2021 Feb; 141(3):. PubMed ID: 33624974
[No Abstract] [Full Text] [Related]
50. [A. B. Houge responds].
Houge AB
Tidsskr Nor Laegeforen; 2022 May; 142(8):. PubMed ID: 35635418
[No Abstract] [Full Text] [Related]
51. Pediatric acute lymphoblastic leukemia.
Inaba H; Mullighan CG
Haematologica; 2020 Nov; 105(11):2524-2539. PubMed ID: 33054110
[TBL] [Abstract][Full Text] [Related]
52. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.
Marke R; van Leeuwen FN; Scheijen B
Haematologica; 2018 Apr; 103(4):565-574. PubMed ID: 29519871
[TBL] [Abstract][Full Text] [Related]
53. Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in
Tozuka T; Noro R; Yoshida K; Takahashi S; Hirao M; Matsuda K; Kato Y; Nakamichi S; Takeuchi S; Matsumoto M; Miyanaga A; Kunugi S; Honda K; Adachi J; Seike M
JTO Clin Res Rep; 2024 Apr; 5(4):100668. PubMed ID: 38646155
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
Srinivasan S; Ramanathan S; Kumar S; Peyam S; Radhakrishnan V
Ann Hematol; 2023 Aug; 102(8):2165-2179. PubMed ID: 37154889
[TBL] [Abstract][Full Text] [Related]
55. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
Conserva MR; Redavid I; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Parciante E; Coccaro N; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834692
[TBL] [Abstract][Full Text] [Related]
56. Reversal of
Butler M; Vervoort BMT; van Ingen Schenau DS; Jongeneel L; van der Zwet JCG; Marke R; Meijerink JPP; Scheijen B; van der Meer LT; van Leeuwen FN
Front Oncol; 2022; 12():905665. PubMed ID: 36119546
[TBL] [Abstract][Full Text] [Related]
57. Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma.
van Erp AEM; Hillebrandt-Roeffen MHS; van Bree NFHN; Plüm TA; Flucke UE; Desar IME; Fleuren EDG; van der Graaf WTA; Versleijen-Jonkers YMH
Sarcoma; 2022; 2022():3089424. PubMed ID: 35655525
[TBL] [Abstract][Full Text] [Related]
58. Focal adhesion kinase inhibitors, a heavy punch to cancer.
Wu Y; Li N; Ye C; Jiang X; Luo H; Zhang B; Zhang Y; Zhang Q
Discov Oncol; 2021 Nov; 12(1):52. PubMed ID: 35201485
[TBL] [Abstract][Full Text] [Related]
59. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.
Zheng W; Wei J; Zebley CC; Jones LL; Dhungana Y; Wang YD; Mavuluri J; Long L; Fan Y; Youngblood B; Chi H; Geiger TL
Blood; 2021 Jul; 138(2):122-135. PubMed ID: 33690816
[TBL] [Abstract][Full Text] [Related]
60. Molecular markers in ALL: Clinical implications.
Kimura S; Mullighan CG
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101193. PubMed ID: 33038982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
